EARLY PRO-2 SYMPTOM REMISSION FOLLOWING GUSELKUMAB INDUCTION TREATMENT: RESULTS THROUGH WEEK 12 OF THE PHASE 2 GALAXI 1 STUDY

Walter Reinisch  ¹     Tadakazu Hisamatsu  ²     Kathleen Weisel  ³     Susana Gonzalez  ³     Mary Ellen Frustaci  ³     Zijiang Yang  ³     Jewel Johanns  ³     Matthew Germinaro  ³     Chenglong Han  ⁴     Jane Andrews  ⁵     Aniita Afzali  ⁶     William Sandborn  ⁷     Brian G. Feagan  ⁸     Omoniyi J. Adedokun  ^8    
1 Medical University of Vienna, Vienna, Austria
² Kyorin University, Tokyo, Japan
³ Janssen Research & Development, LLC, Spring House, United States
⁴ Janssen Global Services, LLC, Malvern, United States
⁵ Royal Adelaide Hospital & University of Adelaide, Adelaide, Australia
⁶ The Ohio State University Wexner Medical Center, Columbus, United States
⁷ University of California San Diego, San Diego, United States
⁸ Robarts Clinical Trials, Western University, London, Canada

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)